Literature DB >> 14605287

A simple risk score predicts poor quality of life and non-survival at 1 year follow-up in dialysis patients.

Peter de Jonge1, G Maarten-Friso Ruinemans, Frits J Huyse, Piet M ter Wee.   

Abstract

BACKGROUND: Quality of life (QoL) in end-stage renal disease patients has become an important focus of attention in evaluating dialysis. We studied risk factors of poor QoL at 1 year follow-up.
METHODS: Of a baseline sample of 80 dialysis patients, we contacted 60 patients who were alive at 1 year follow-up. QoL data were obtained for 46 (76.7%) of these patients. QoL measured with the SF-36 [physical health component score (PCS) and mental health component score (MCS)] at 1 year-follow-up was predicted by means of multivariate regression analysis by data collected at baseline using INTERMED-an observer-rated method to assess biopsychosocial care needs-and several indicators for disease severity and comorbidity.
RESULTS: The regression models explained 32% of the variance in PCS and 40% in MCS. INTERMED score (P < 0.01) was the only independent risk factor for low MCS, while for low PCS, diabetic comorbidity (P = 0.02) and age (P = 0.03) were independent risk factors. A simple risk score consisting of INTERMED > or =21, diabetic comorbidity and age > or =65 was significantly correlated with non-survival (P = 0.02) and with PCS (P < 0.01) and MCS (P < 0.01) in surviving patients, although not with hospital admissions during follow-up.
CONCLUSIONS: A simple risk score based on INTERMED, age (> or =65) and comorbid diabetes (yes/no) can be used to detect patients at risk of poor QoL and non-survival at an early stage of treatment.

Entities:  

Mesh:

Year:  2003        PMID: 14605287     DOI: 10.1093/ndt/gfg453

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Negative trials in nephrology: what can we learn?

Authors:  James E Novak; Jula K Inrig; Uptal D Patel; Robert M Califf; Lynda A Szczech
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

2.  Reliability of INTERMED Spanish version and applicability in liver transplant patients: a cross-sectional study.

Authors:  Elena Lobo; M José Rabanaque; M Luisa Bellido; Antonio Lobo
Journal:  BMC Health Serv Res       Date:  2011-07-05       Impact factor: 2.655

3.  Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?

Authors:  Laurent Michaud; Gundula Ludwig; Sylvie Berney; Stéphanie Rodrigues; Anne Niquille; Valérie Santschi; Anne-Sophie Favre; Anne-Catherine Lange; Annemieke A Michels; Bernard Vrijens; Olivier Bugnon; Nathalie Pilon; Manuel Pascual; Jean-Pierre Venetz; Friedrich Stiefel; Marie-Paule Schneider
Journal:  Pharm Pract (Granada)       Date:  2016-12-15

4.  Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Authors:  Joerg Seckinger; Wilfried Dschietzig; Gerd Leimenstoll; Peter M Rob; Martin K Kuhlmann; Wolfgang Pommer; Uwe Fraass; Eberhard Ritz; Vedat Schwenger
Journal:  Clin Kidney J       Date:  2016-09-26

5.  Health complexity assessment in primary care: A validity and feasibility study of the INTERMED tool.

Authors:  Camila Almeida de Oliveira; Bernardete Weber; Jair Lício Ferreira Dos Santos; Miriane Lucindo Zucoloto; Lisa Laredo de Camargo; Ana Carolina Guidorizzi Zanetti; Magdalena Rzewuska; João Mazzoncini de Azevedo-Marques
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

6.  Patterns of health-related quality of life and associated factors in Chinese patients undergoing haemodialysis.

Authors:  Eric Y F Wan; Julie Y Chen; Edmond P H Choi; Carlos K H Wong; Anca K C Chan; Karina H Y Chan; Cindy L K Lam
Journal:  Health Qual Life Outcomes       Date:  2015-07-29       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.